All In MedTech

FDA Clearance Tracker · P110021-S023

EDWARDS SAPIEN TRANSCATHETER HEART VALVE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 13, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P110021-S023
Device name
EDWARDS SAPIEN TRANSCATHETER HEART VALVE
Applicant location
Irvine, CA
Received
Jul 17, 2013
Decided
Sep 13, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P110021

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.